Other studies to prevent pulmonary fibrosis suggest that inhibitors of upregulated genes (MMP8, PDE4) in patients with pulmonary fibrosis might be a therapeutic target [124,125,126]. This evidence concerns the gene MMP8 and pulmonary fibrosis.